Impact of a High-fat Meal on Assessment of Clopidogrel-induced Platelet Inhibition in Healthy Subjects
NCT01307657 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2023-09-01
Summary
The purpose of this study is to determine whether a high-fat meal affects the ability of platelet function tests to measure platelet inhibition by clopidogrel.
Conditions
- Healthy
Interventions
- OTHER
-
high fat meal
Clopidogrel 600 mg loading dose at 8 am and high-fat meal at 12 pm
Sponsors & Collaborators
-
University of Nebraska
lead OTHER
Principal Investigators
-
Julie Oestreich, PharmD, PhD · University of Nebraska
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-02-15
- Primary Completion
- 2012-03-01
- Completion
- 2012-03-01
Countries
- United States
Study Locations
More Related Trials
-
Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Body Mass Index ≥ 27
NCT01509365 ·Status: COMPLETED ·Phase: PHASE4
-
Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease.
NCT01011257 ·Status: WITHDRAWN ·Phase: PHASE4
-
Clopidogrel Preventive Effect Based on CYP2C19 Genotype in Ischemic Stroke
NCT04072705 ·Status: COMPLETED
-
Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting Conditions
NCT01506713 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Atorvastatin Versus Pravastatin on Platelet Inhibition by Clopidogrel
NCT00405717 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Clopidogrel Loading and Risk of PCI
NCT00457236 ·Status: UNKNOWN
-
Effects of Clopidogrel on Blood Pressure
NCT01112137 ·Status: COMPLETED ·Phase: PHASE4
-
Influence of CYP2C19 Genetic Variants on Clopidogrel in Healthy Subjects
NCT00413608 ·Status: COMPLETED ·Phase: PHASE1
-
Platelet Reactivity in Stent Thrombosis Patients
NCT01012544 ·Status: COMPLETED ·Phase: PHASE4
-
Platelet-dependent Thrombosis: a Placebo-controlled Trial of Antiplatelet Therapy (Clopidogrel)
NCT00728156 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Bioavailability Study of Two Oral Formulations of Clopidogrel
NCT01447563 ·Status: TERMINATED ·Phase: PHASE1
-
Influence of Clopidogrel on the Pharmacodynamics and Safety of Terbogrel in Healthy Male Subjects
NCT02222987 ·Status: COMPLETED ·Phase: PHASE1
-
Clopidogrel Response and CYP2C19 Genotype in Ischemic Stroke Patients
NCT03385538 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial to Evaluate the Influence of Genotype on the Pharmacokinetics/Pharmacodynamics of Clopidogrel
NCT01503658 ·Status: COMPLETED ·Phase: PHASE4
-
Platelet Function Monitoring in Patients Treated With Clopidogrel at the Time of Primary Percutaneous Coronary Angioplasty
NCT00827346 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effect of Genetic Polymorphism on Interactions of Clopidogrel and Cilostazol in Healthy Volunteers
NCT01482117 ·Status: COMPLETED ·Phase: NA
-
Pharmacodynamic and Pharmacokinetic Study of 2 Different Dose Regimen of Clopidogrel in CYP2C19 Genotyped Healthy Subjects
NCT01123824 ·Status: COMPLETED ·Phase: PHASE1
-
Genetic Polymorphism Associated With Coronary Heart Disease Susceptibility and Variability of Clopidogrel Response
NCT03373552 ·Status: ACTIVE_NOT_RECRUITING
-
Comparative Pharmacodynamics and Pharmacokinetics Study of Generic and Reference Clopidogrel Products
NCT02010632 ·Status: COMPLETED ·Phase: PHASE1
-
Relationship Between Dosage of Clopidogrel and Platelet Aggregation in Chinese With Different Genotype
NCT01710436 ·Status: UNKNOWN
-
Influence of Clopidogrel on the Pharmacodynamics and Safety of Fradafiban in Healthy Male Subjects
NCT02265289 ·Status: COMPLETED ·Phase: PHASE1
-
Platelet Function Analysis in Head Trauma: ASA/Plavix
NCT01534117 ·Status: COMPLETED ·Phase: NA
-
Evaluation and Comparison of Several Point-of-care Platelet Function Tests in Predicting Clinical Outcomes in Clopidogrel Pre-treated Patients Undergoing Elective PCI.
NCT00352014 ·Status: COMPLETED
-
Pharmacodynamic Study of Cilostazol in Healthy Volunteers
NCT02554721 ·Status: COMPLETED ·Phase: PHASE1
-
The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A
NCT00004564 ·Status: UNKNOWN ·Phase: NA